Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 09:14 am Purchase | 2023-12-31 | 13G | ATEA PHARMACEUTICALS INC AVIR | BML Investment Partners, L.P. | 5,602,079 6.700% | 1,418,434 (+33.90%) | Filing History |
| 2024-01-16 5:54 pm Purchase | 2024-01-10 | 13G | RENEO PHARMACEUTICALS INC RPHM | BML Investment Partners, L.P. | 169,423 5.100% | 169,423 (New Position) | Filing History |
| 2024-01-16 5:24 pm Purchase | 2024-01-11 | 13G | ACLARIS THERAPEUTICS INC ACRS | BML Investment Partners, L.P. | 4,500,000 6.400% | 4,500,000 (New Position) | Filing History |
| 2024-01-10 5:39 pm Purchase | 2024-01-10 | 13D | FORTE BIOSCIENCES FBRX | BML Investment Partners, L.P. | 70,468 4.800% | 1,065 (+1.53%) | Filing History |
| 2023-11-24 11:33 am Purchase | 2023-11-13 | 13G | RAIN ONCOLOGY INC. RAIN | BML Investment Partners, L.P. | 1,815,953 6.600% | 1,815,953 (New Position) | Filing History |
| 2023-10-02 11:45 am Purchase | 2023-09-25 | 13G | ATEA PHARMACEUTICALS INC AVIR | BML Investment Partners, L.P. | 4,183,645 5.000% | 4,183,645 (New Position) | Filing History |
| 2023-09-15 12:00 pm Unchanged | 2023-09-15 | 13D | FORTE BIOSCIENCES FBRX | BML Investment Partners, L.P. | 69,403 4.780% | 0 (Unchanged) | Filing History |
| 2023-07-24 3:23 pm Purchase | 2023-07-13 | 13G | AVROBIO INC AVRO | BML Investment Partners, L.P. | 330,450 9.000% | 330,450 (New Position) | Filing History |
| 2023-07-17 11:07 am Purchase | 2023-07-06 | 13G | QUINCE THERAPEUTICS, INC QNCX | BML Investment Partners, L.P. | 1,841,301 5.070% | 1,841,301 (New Position) | Filing History |
| 2023-06-26 4:00 pm Unchanged | 2023-06-26 | 13D | ASTROTECH CORP COM PAR $ ASTC | BML Investment Partners, L.P. | 232,065 13.700% | 0 (Unchanged) | Filing History |
| 2023-06-12 6:57 pm Sale | 2023-06-08 | 13G | SATSUMA PHARMACEUTICALS INC CO STSA | BML Investment Partners, L.P. | 0 0.000% | -6,590,000 (Position Closed) | Filing History |
| 2023-04-27 2:19 pm Unchanged | 2023-04-17 | 13G | TALARIS THERAPEUTICS INC TALS | BML Investment Partners, L.P. | 218,919 5.200% | 0 (Unchanged) | Filing History |
| 2023-04-27 10:55 am Purchase | 2023-04-17 | 13G | TALARIS THERAPEUTICS INC TALS | BML Investment Partners, L.P. | 218,919 5.200% | 218,919 (New Position) | Filing History |
| 2023-03-29 11:17 am Purchase | 2023-03-24 | 13D | FORTE BIOSCIENCES FBRX | BML Investment Partners, L.P. | 69,403 8.260% | 10,948 (+18.73%) | Filing History |
| 2023-03-17 10:15 am Purchase | 2023-03-09 | 13G | EMBARK TECHNOLOGY INC EMBK | BML Investment Partners, L.P. | 994,355 5.200% | 994,355 (New Position) | Filing History |
| 2023-02-08 5:29 pm Sale | 2023-02-08 | 13G | ASTROTECH CORP COM PAR $ ASTC | BML Investment Partners, L.P. | 232,065 13.700% | -5,247,257 (-95.76%) | Filing History |
| 2023-02-08 5:24 pm Unchanged | 2023-02-08 | 13G | TERNS PHARMACEUTICALS INC TERN | BML Investment Partners, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-08 5:23 pm Sale | 2023-02-08 | 13G | TERNS PHARMACEUTICALS INC TERN | BML Investment Partners, L.P. | 0 0.000% | -1,764,274 (Position Closed) | Filing History |
| 2023-02-08 5:09 pm Unchanged | 2023-02-08 | 13G | PARDES BIOSCIENCES INC PRDS | BML Investment Partners, L.P. | 4,867,984 7.800% | 0 (Unchanged) | Filing History |
| 2023-02-08 5:06 pm Unchanged | 2023-02-08 | 13G | GRAYBUG VISION INC GRAY | BML Investment Partners, L.P. | 88,282 5.700% | 0 (Unchanged) | Filing History |